Geoffrey E. Harris Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Geoffrey E. Harris.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Geoffrey E. Harris. Geoffrey E. Harris is a Director in MYnd Analytics, Inc. ($CNSO) and a Director in American CareSource Holdings, Inc. ($GNOW) and a Director in CANCER GENETICS, INC ($CGIX).
Address: C/O AMERICAN CARESOURCE HOLDINGS, INC. 5429 LYNDON B JOHNSON FREEWAY, SUITE 850 DALLAS 75240 TX
Companies in which Geoffrey E. Harris is an Insider
American CareSource Holdings, Inc.
Industry: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
Position of Geoffrey E. Harris: Director
Holdings: 20,000 shares
Current Value: $200
Latest Transaction: Sep 01 2015
$GNOW Market Capitalization: $116179.00
$GNOW Previous Close: $0.01
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Emmaus Life Sciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Geoffrey E. Harris: Director
Holdings: 97,110 shares
Current Value: $873,990
Latest Transaction: Oct 10 2018
$MYND Market Capitalization: $20.06M
$MYND Previous Close: $9.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vyant Bio, Inc.
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Geoffrey E. Harris: Director
Holdings: 127,500 shares
Current Value: $306,000
Latest Transaction: Apr 01 2021
$CGIX Market Capitalization: $42.50M
$CGIX Previous Close: $2.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Geoffrey E. Harris
Sentiment: All, GNOW, MYND, CGIX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | CGIX | Vyant Bio, Inc. | Harris Geoffrey E. | Director | Option Exercise | A | 4.61 | 13,015 | 59,999 | 13,015 | |
| Apr 01 2021 | CGIX | Vyant Bio, Inc. | Harris Geoffrey E. | Director | Option Exercise | A | 4.61 | 13,015 | 59,999 | 13,015 | |
| Aug 19 2019 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Option Exercise | A | 0.15 | 100,000 | 15,000 | 100,000 | |
| Jan 16 2019 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Buy | P | 0.23 | 100,000 | 22,500 | 127,500 | 27.5 K to 127.5 K (+363.64 %) |
| Jan 16 2019 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Buy | P | 0.23 | 100,000 | 22,500 | 127,500 | 27.5 K to 127.5 K (+363.64 %) |
| Oct 10 2018 | MYAN | MYnd Analytics, In ... | Harris Geoffrey E. | Director | Grant | A | 1.38 | 45,000 | 62,100 | 97,110 | 52.1 K to 97.1 K (+86.36 %) |
| Dec 07 2017 | MYAN | MYnd Analytics, In ... | Harris Geoffrey E. | Director | Buy | P | 3.80 | 3,500 | 13,300 | 52,110 | 48.6 K to 52.1 K (+7.20 %) |